Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Clinical Kidney Journal|August 24, 2022
Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patientsAlice Chimon, Elsa Ferrière, Mohamed Ali Lammouchi, et al.
Nature Immunology|September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccinationJeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Annals of Intensive Care|June 28, 2024
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024Nicolas de Prost, Etienne Audureau, Antoine Guillon, et al.
Nature Communications|January 9, 2024
IgM N-glycosylation correlates with COVID-19 severity and rate of complement depositionBenjamin S Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, et al.
Leukemia|July 10, 2021
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progressionL C Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
International Journal of Antimicrobial Agents|April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failureAnne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 26, 2024
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024Alice Moisan, Hadrien Regue, Yannis Rahou, et al.
Communications Medicine|March 10, 2026
Prospective multicentre study of upper respiratory mucosal transcriptomics reveals two major endotypes of critically ill COVID-19 patientsPierre Bay, Laure Boizeau, Sébastien Préau, et al.
Scientific Data|October 20, 2022
The Immune Signatures data resource, a compendium of systems vaccinology datasetsJoann Diray-Arce, Helen E R Miller, Evan Henrich, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Clinical Kidney Journal|August 24, 2022
Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patientsAlice Chimon, Elsa Ferrière, Mohamed Ali Lammouchi, et al.
Nature Immunology|September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccinationJeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Annals of Intensive Care|June 28, 2024
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024Nicolas de Prost, Etienne Audureau, Antoine Guillon, et al.
Nature Communications|January 9, 2024
IgM N-glycosylation correlates with COVID-19 severity and rate of complement depositionBenjamin S Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, et al.
Leukemia|July 10, 2021
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progressionL C Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
International Journal of Antimicrobial Agents|April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failureAnne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 26, 2024
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024Alice Moisan, Hadrien Regue, Yannis Rahou, et al.
Communications Medicine|March 10, 2026
Prospective multicentre study of upper respiratory mucosal transcriptomics reveals two major endotypes of critically ill COVID-19 patientsPierre Bay, Laure Boizeau, Sébastien Préau, et al.
Scientific Data|October 20, 2022
The Immune Signatures data resource, a compendium of systems vaccinology datasetsJoann Diray-Arce, Helen E R Miller, Evan Henrich, et al.
Pageof 19